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Abstract
Synthetic materials have long been used to provide structural support when surgically 
repairing pelvic organ prolapse (POP). The most widely used synthetic material is a 
mesh made of polypropylene (PPL). The use of mesh is intended to improve cure rates 
and prevent recurrences after POP surgery – however as more mesh materials have been 
implanted, it has become apparent that serious complications can occur in up to 30% of 
women, particularly when the mesh is implanted transvaginally. Over the years many dif-
ferent mesh kits have been marketed and used in the treatment of POP however polypro-
pylene mesh was never designed or tested for use in pelvic floor. Instead it was approved 
for clinical use based on its biocompatibility and success in abdominal hernia repairs. It 
is now known that PPL meshes are neither compliant with the mechanical forces in the 
pelvic floor nor do they integrate well into paravaginal tissues. Better materials developed 
specifically for use in pelvic floor are urgently needed. The aim of this chapter is to define 
the requirements of an ideal mesh in terms of its material properties and to summarize the 
ongoing research on developing the next generation pelvic floor repair materials.
Keywords: pelvic organ prolapse, mesh, polypropylene, implant material, 
biomechanical properties
1. Introduction
Pelvic organ prolapse (POP) is the descent of one or more of the anterior vaginal wall, pos-
terior vaginal wall, the uterus (cervix) or the apex of the vagina (after hysterectomy) which 
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correlates with patients’ symptoms [1]. Prolapse of the anterior vaginal wall (or a cystocele) is 
the most common type of POP followed by a uterine or vault prolapse and rectal prolapse [2], 
although they coexist in most patients presenting with symptomatic POP.
Some degree of POP is seen in up to 30–76% of women who have their routine gynaecological 
examinations [3]. Most of these will be early stage/mild prolapses and cause no symptoms 
[4]. Although only 3–6% of these cases will have any symptoms, the lifetime risk of a women 
in the general population undergoing a POP surgery has been reported to be 20% (excluding 
hysterectomy cases) [3]. As the population ages the prevalence of POP is estimated to increase 
substantially by 46% between 2010 and 2050 [5].
Reconstructive surgery to improve positioning of the pelvic organs or to restore the supporting 
structures is often necessary in symptomatic cases and the use of a graft material is often needed 
to reinforce weakened tissues. The most commonly used material is a surgical mesh made of 
polypropylene (PPL) which has long been used successfully to treat hernias. Although mesh aug-
mented POP repair procedures have higher anatomical success rates compared to no-mesh, the 
functional and quality of life outcomes are not as good [6] and severe complications with life 
changing consequences can occur in up to 10–30% of cases [7]. Complications associated with the 
use of vaginal mesh are now reported widely in the media together with many litigations against 
physicians and manufacturers leading to the withdrawal of several mesh products from the USA 
market [8]. In the UK there are now 800 compensation claims made against the NHS in relation 
to vaginal mesh related complications [9]. In 2008 and 2011 the Food and Drug Administration 
(FDA) of United States of America released two public health warnings related to mesh complica-
tions [10] which was followed by statements from Medicines and Healthcare products Regulatory 
Agency (MHRA) in United Kingdom [11] and the European Commission [12]. Consequently 
transvaginal meshes were re-classified from being class II (a moderate risk device) to class III (a 
high risk device) making pre-market approval necessary before new devices could be marketed 
[13]. As a consequence the relative number of mesh augmented transvaginal POP repair proce-
dures decreased sharply from 27 to 2%, among all other types of POP surgeries [14]. The number 
of mesh sling surgeries for treatment of stress urinary incontinence has also decreased [15].
Factors affecting occurrence of mesh related complications can broadly be classified as factors 
related to the material itself and factors related to the application of the material [16]. Material 
properties involve the composition of the polymer used, total bulk of the material used and its 
biocompatibility, mechanical properties and ultrastructure such as pore size and knit pattern. 
Factors related to the application of the material are the surgical technique used, the route of 
implantation [transvaginal vs. transabdominal], surgeon’s experience and patient related fac-
tors [obesity, smoking status, etc.].
In this chapter we will first explore the evolvement of the surgical mesh as a material used 
in abdominal hernia repair together with the modifications made to the surgical technique of 
implantation to improve patient outcomes. We then move on to define the mechanical and 
biological properties of the female pelvic floor to determine the design requirements of the 
ideal pelvic floor repair material. Finally we will look at the current approaches to develop 
novel materials using mainly biomaterials and tissue engineering techniques with reference 
to some of the work from our own group.
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2. The use of materials in pelvic surgery
In pelvic organ prolapse surgeries, prosthetic materials are either needed to reinforce the 
surgical repair site in anterior and posterior vaginal wall defect repairs or to suspend the 
prolapsed uterus or vaginal vault in sacrocolpopexy operations [17]. Surgeries performed for 
stress urinary incontinence use this material under the urethra as a sling.
The ideal prosthetic material is desired to provide a durable structural support without caus-
ing significant complications such as pain, compromise in vaginal capacity or sexual func-
tions. A wide variety of synthetic and biological materials have been used over the years as 
prosthetics however the perfect material is still to be developed.
Biological materials are mostly in the form of biological grafts from the patient’s own tissues 
from abdomen (rectus fascia) or thigh (fascia lata). These autologous fascia have long been 
used as a sling in the treatment of stress urinary incontinence [18]. The obvious limitation of 
using an autologous fascia is increased perioperative morbidity, donor site morbidity and 
lack of availability of enough material in some patients who require repeated procedures or 
have large areas of fascia defect. Using natural fascia from allogeneic (e.g. cadaveric) or xeno-
geneic (e.g. bovine dermis) sources has also been used over the years but these carry a small 
risk of prion and Human Immunodeficiency Virus transmission. Also the decellularization, 
sterilization and other processing methods are known to adversely influence the biomechani-
cal properties of the fascia [19]. The clinical efficacy of biological implants are still controver-
sial with some studies showing high anatomical and functional failure rates [20, 21] whereas 
others report results comparable to mesh repairs in less severe cases of POP [22].
A basic understanding of the material properties of the available grafts and the physiological 
requirements of the site of implantation is required to select the best material for a specific 
application.
3. Evolvement of the polypropylene mesh as a material
The concept of using a prosthetic material to reinforce a fascial defect was first developed to treat 
hernias. Theodore Billroth (1829–1894) stated that “If we could artificially produce tissues of the 
density and toughness of fascia and tendon the secret of the radical cure of hernia would be 
discovered” Czerny [23]. The first mesh material was made of metal. In 1902 silver filigrees were 
used to treat difficult to treat hernias [24]. The silver wires and other metals (tantalum and stain-
less steel) were used until recently [25] with reasonable success rates to treat large hernia defects 
however they were eventually abandoned due to their association with excessive abdominal stiff-
ness, sinus tract formation, metal failure (corrosion and fragmentation) and patient discomfort.
Following the plastics revolution in 20th century and the advancements in polymer science 
many diagnostic and therapeutic medical and surgical instruments made of plastic became 
available. Plastics had obvious advantages over metals in soft tissue reconstruction with their 
ductility, lightweight and handleability [26]. Among the plastics used, polypropylene (PPL) 
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possessed favorable physical properties such as high tensile strength with easy handleabil-
ity. It could be made into a monofilament, have a high softening temperature (260°F), non 
wettable and resistant to chemicals. Usher first manufactured and experimentally tested first 
plastic mesh made of polypropylene [27]. The initial experimental data in dogs with knitted 
PPL confirmed that it allowed tissue ingrowth in between its fibers, it was strong with excel-
lent tensile properties and it was resistant to infections when compared to other plastics.
The use of synthetic mesh has revolutionized hernia repair surgeries reducing the recurrence 
rates by 2–3 fold compared to traditional suture repairs [28]. However looking retrospectively 
it appears that PPL was far from being complication-free when first introduced into abdomi-
nal hernia repairs. Over the years, both the surgical implantation site and the material prop-
erties of the PPL have been modified to reduce the complication rates of mesh augmented 
abdominal hernia repair surgeries. A brief revision of the improvements made to the surgical 
technique and material characteristics over many years can provide a better understanding of 
the current clinical problem related to vaginal mesh products.
The initial plastic mesh was prepared from a monofilament 8 mils in diameter (200 μm), 42 × 40 
per inch thread count by a simple taffeta weave. This mesh was then autoclaved and cut into 
desired patterns before implantation [33]. On the other hand, the modern surgical mesh con-
structed from a knitted polypropylene has smaller pores with an area density of 90–95 g/m2. These 
heavy-weight, first generation meshes are now known to cause a vigorous foreign body reaction 
and resulting dense scar tissue leading to a loss of the compliance of the abdominal wall [34].
Over the next few years heavy weight meshes were replaced by medium to light weight 
meshes that reduced the bulk of the foreign material leading to less inflammation, foreign 
body reaction, fibrosis and the associated pain sensation [34]. Also the pore sizes were made 
larger (macroporous). A study demonstrated that the bulk density of PPL (Prolene®) mesh 
could be reduced down to 25% of its original weight without significantly compromising its 
efficacy with reduced major and minor complications [35]. Also clinical studies comparing 
1902 [24] First prosthetic mesh (silver filigrees) to be routinely used to treat difficult to treat hernias.
1940 [29] Tantalum gauze fabric introduced
1948 [30] Formation of a darn using a Nylon suture for inguinal hernia repair.
1963 Francis Usher (1908–1980) introduced first woven, plastic mesh made of polypropylene for hernia repair.
1995 [31] Ulmsten and Petros described the Integral theory of stress urinary continence and performed the first 
intravaginal mesh-sling surgery
1996* PPL (Marlex®) received FDA clearance for SUI.
1998* First lightweight PPL mesh introduced.
2002* First mesh product for POP (Gyneacare®).
2004* First ‘mesh kit’ (Apogee®, Perigee®) cleared by FDA for POP.
*Reviewed in Dällenbach [32].
Table 1. Milestones in the development of surgical mesh materials and their use in pelvic floor disorders.
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heavy and light-weight mesh materials implanted for inguinal hernia repairs demonstrated 
less pain and less sensation of a foreign material with lighter meshes [36]. Thus the polypro-
pylene mesh evolved over the years from a heavy weight, small pore sized mesh to a light-
weight, and large pore sized mesh material.
Efforts to make further improvements to the current surgical mesh are still ongoing. One 
strategy to modify the geometry/knitting pattern of PPL to make it mechanically more com-
pliant with the pelvic floor [37]. Another strategy is enhancing the biocompatibility of PPL 
by coating it with more biocompatible materials to obtain a more favorable tissue response. 
An extracellular matrix coated PPL when implanted in rats demonstrated an inflammatory 
response that is more reflective of a tissue remodeling type rather than a fibrotic one [38]. 
There has also been research on degradable and hybrid degradable/nondegradable mesh 
materials. The main idea behind a degradable mesh was that it would be absorbed after a 
period of time by which time the patients’ own tissues would have recovered and this would 
avoid the long term complications of permanent mesh like infection and fistula formation. 
Nevertheless polypropylene is still the most widely used polymer in mesh products used 
clinically at the time of writing.
4. Modifications to the surgical technique to improve outcomes of 
mesh-augmented hernia repairs
In parallel to improvements made to the material, modifications to the surgical technique were 
also made to reduce side effects and recurrences. Advances in both inguinal and abdominal her-
nia repair techniques can be observed mainly led by Usher and Rives [39]. Usher has also made 
contributions to developing the technique of hernia repair, mainly he introduced the concept of 
buttressing a sutured repair instead of bridging the gap with a mesh. On other words the mesh 
would not only just fit in the hole but be 2–3 cm larger to underlap with the underlying tissues.
We will only review the improvements made to the surgical approach to incisional hernia 
repair in the abdominal wall, where we feel it is relevant to the pelvic floor repair. The abdomi-
nal hernia repair technique evolved from an ‘inlay technique’ where the mesh is placed in-
between the edges of the fascia defect to an ‘onlay technique’ where the mesh was placed on 
top of the repaired fascia defect in a tension-free manner. To further reduce the complications 
of mesh augmented repairs, a ‘sublay (retrorectus) technique’ was introduced where the mesh 
was placed underneath a well vascularized, thick muscle tissue (the rectus abdominis muscle) 
in-between two fascial layers (Figure 1). Proximity to a well vascularized wound bed is argu-
ably a key factor in the success of this technique [40]. Additionally in the sublay technique, as 
opposed to inlay and onlay, mesh had less contact with subcutaneous tissues that prevented 
transmission of the infection from subcutaneous tissues to the mesh as it lies quite deep in the 
abdominal wall [41]. Abdominal hernias are heterogeneous with regards to why they occur and 
how extensive they are. No single technique is suitable or feasible for all types of hernias and 
different methods of repair may be indicated for specific defects and locations. Nevertheless 
the sublay technique appears to be superior to other techniques particularly in difficult to treat 
wound beds (for example poorly vascularized or repeatedly operated wounds) [42, 43].
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5. The failure of PPL in the pelvic floor
The first use of polypropylene in the pelvic floor was based on the integral theory [44]. The 
integral theory of female stress urinary incontinence stated that the pubourethral ligament in 
women creates a physiologic ‘backboard’ by fixing the mid-urethra to the pubic bone and that 
the laxity of this ligament results in the loss of the backboard inhibiting the urethral coapta-
tion during times of increased intra-abdominal pressure that results in urinary incontinence. 
The synthetic midurethral slings (MUS) based on the integral theory came as a minimally 
invasive treatment modality with very high success rates. The initial description of the meth-
odology used plastic tapes with the patient under local anesthesia [31]. The high initial suc-
cess rates of the minimally invasive, relatively easy to perform MUS operations soon led to the 
use of the PPL mesh for transvaginal repair of pelvic organ prolapse.
The POP occurs as a result of loss of support at three levels in the pelvis. Level I cardinal-uterosacral 
ligaments providing apical support, level II arcus tendineus fascia pelvis supporting middle 
part of vagina laterally and level III urogenital diaphragm and perineal body supporting lower 
part of the vagina [45]. The contribution of each of these structures to occurrence of prolapse 
as we see it in the clinic, is not well defined. A recent work, for example, suggests that lack of 
vaginal apical support was a significant contributor to the occurrence of anterior compartment 
Figure 1. Graphical demonstration of surgical implantation sites of mesh material in relation to muscle and fascia in 
abdominal hernia repairs. (A) A cross section of anterior abdominal wall with a fascia defect causing hernia can be seen 
with muscle (red), fascia (black) and mesh (blue) labeled in different colors. (B) Inlay mesh implantation to fit in the gap 
created by the fascia and muscle defect. This method was largely abandoned due to high recurrence rates. (C) Onlay 
placement of mesh material to overlie and reinforce the fascia and muscle defect. (D) In the sublay technique mesh 
material is placed on a well vascularized wound bed underneath the muscle and it is also covered by two fascial layers. 
This technique is considered the current gold standard with less complication and high success rates.
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prolapse and that correcting the apical descent when treating cystoceles would reduce re-oper-
ation rates [46]. Thus the exact pathophysiology of POP, its correlations with clinical presen-
tations and the theoretical basis of surgical techniques performed to treat POP are not well 
described. Nevertheless most of POP repair procedures are performed via a vaginal route 
(transvaginally) [47] either by placing the mesh directly on to the native tissue repair or suturing 
it to a strong ligament such as the sacrospinous ligament or arcus tendinous fascia pelvis [17]. 
Regardless of at what level the defect is and what the mesh restores, the transvaginal POP repair 
is more reflective of an onlay technique (mesh onlay repair) which did not work very well in 
the abdomen arguably due to being prone to be colonized by skin microbial flora as it lies very 
close to the skin [48]. Additionally, the mesh is not placed on a well vascularized wound bed in 
mesh onlay vaginal repairs. This can have particular importance in the postmenopausal women 
undergoing these operations as they already have poorly oestrogenised tissues.
In addition to the limitations related to the surgical technique of implantation, the PPL 
mesh also has some inherent characteristics that make it unsuitable for use in pelvic floor. 
Recent animal studies in sheep confirmed a site specific response to implanted PPL mesh, 
where a 5 × 5 cm piece of PPL mesh led to contraction and erosion in 3 out of 10 sheep in 
12 months when implanted vaginally in contrast to no erosions in abdominal implantations 
[49]. The animal studies also showed that the host response to the PPL initiated by macro-
phages in the mesh-tissue interface was mainly an M1 (proinflammatory) response, instead 
of an M2 (remodeling) response, characterized by secretion of matrix metalloproteinases 
and pro-inflammatory cytokines leading to a vigorous foreign body reaction [50]. An M2 
response is favorable for tissue integration while an M1 dominated response is now thought 
to explain the pain associated with mesh and mesh exposure. Clinical data obtained from 
women who underwent mesh excision due to severe pain or mesh exposure also confirmed 
that there was an M1 predominant macrophage response observed in the histological sec-
tions of the mesh-vagina explants [51]. Essentially a high M1 response indicates persistent 
inflammation. Thus there is a site-specific response to PPL mesh and the failure of PPL in 
the pelvic floor is partially due to the unfavorable mesh-tissue interaction leading to poor 
tissue integration.
In conclusion the use of mesh evolved over many years from an initial metal wire mesh to the 
monofilament, macroporous PPL mesh used in contemporary practice. Together with the improve-
ments made in the surgical implantation technique mesh augmented surgical repairs now have 
very reasonable success rates in abdominal hernia surgeries. Although some of these improve-
ments made to the material have been translated to the pelvic floor, we know that the same mate-
rial when implanted vaginally to treat POP has resulted in unacceptably high complication rates.
This can be partially explained by factors related to the current surgical technique. The standard 
surgical technique, particularly those of transvaginal POP repairs, may need further improve-
ments which will clearly require a better understanding of the pathophysiology of POP in women. 
Another important aspect is related to the pre and postoperative factors. It is now recognized 
that mesh augmented pelvic floor repair procedures, although conducted as minimally invasive 
day case procedures, involve placement of a permanent implant into the patients’ body making 
post implantation surveillance necessary [12, 16]. Also factors related to patient selection, espe-
cially when the patients have co-morbidities such as diabetes and obesity, are known to influence 
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postoperative outcomes. Surgeons’ experience is another potentially important factor in the mesh 
implant procedures. Several recent consensus reports on how to control vaginal mesh related 
complications are now emphasizing that only surgeons/centers with subspecialist experience on 
implantation and postoperative management of patients with stress urinary incontinence and 
pelvic organ prolapse should undertake these procedures. Also the implementation of national 
mesh registries, thus not relying solely on the manufacturers to report mesh related adverse event 
and mandatory post-implantation surveillance systems are recommended.
6. Designing synthetic materials to be used in pelvic floor reconstruction
The PPL vaginal meshes in current clinical use were never designed or tested specifically for 
use in pelvic floor. Instead they were cleared in regulatory terms based on their biocompat-
ibility and the similarity of their textile properties to the existing abdominal hernia products 
via a 510(k) loophole. In other words, PPL mesh was used in pelvic floor based on an assump-
tion that if it worked well in the abdomen to reinforce hernia repairs it would work equally 
well to support vaginal prolapse repairs. It is now being recognized that this approach was 
inherently flawed as the microbial flora, pH, vascular supply and physiological mechanical 
requirements of the pelvic floor are different from that of the abdomen.
Novel synthetic materials that are mechanically compatible with the requirements of the pel-
vic floor and that can effectively integrate into host tissues after implantation can be designed 
by using biomaterials and tissue engineering techniques. This requires an in depth under-
standing of the mechanical and biochemical properties of the pelvic floor. This section will 
review the available evidence on the biomechanics of the pelvic floor with a view to defining 
the design requirements for pelvic floor tissue engineering.
6.1. Basic definitions in biomechanics
The pelvic floor is the hammock-like structure made up of skeletal and smooth muscles sur-
rounded by connective tissues and attached to pelvic bones. Its’ main function is to counteract 
the forces generated by gravity and intra-abdominal pressure. When studying bioengineering 
of the pelvic floor we need to consider its biological constitution in relation to the mechani-
cal forces acting on it. Namely, any material used to support the pelvic floor needs to have 
defined characteristics of material deformation and load bearing as well as how it contributes 
to tissue remodeling once it is implanted in to the body. It is important that clinicians/sur-
geons have a basic understanding of biomechanical principles so that they can define the bio-
mechanics of the tissue to be replaced and select the best material to meet the specific needs.
Briefly, when a force is applied to a material it cause a change in size or shape of the mate-
rial (deformation). This is most commonly expressed in a stress-strain curve from a uniaxial 
tensile test (Figure 2). This test gives an idea about the maximum forces needed to break 
the material (ultimate tensile strength) and the point where plastic deformation starts (yield 
strength). These parameters need to be considered together with the requirements of the site 
of implantation when designing an implant material.
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6.2. Defining the mechanical characteristics of the native human pelvic floor
Our knowledge on the mechanical properties of the female pelvic floor mainly comes from 
mechanical testing of samples from the pelvic floor from human and animal samples. The 
availability of human samples for mechanical testing is often limited due to challenges and 
ethical concerns related to obtaining large tissue samples. Whole pelvic floor samples of ani-
mals that contain all the muscles and the connective tissues of the pelvic floor (e.g. ‘vaginal sup-
portive tissue complex’) have been obtained from rats demonstrating that the ultimate failure 
in the testing protocol was due to a failure of paravaginal attachments [52]. Samples that only 
contain the connective tissues (e.g. fascia) have also been tested [53]. Disruption in the fascial 
structures is thought to be the main mechanism by which pelvic organ prolapse occurs [52].
Another factor limiting our ability to have robust definitions of mechanical properties of pelvic 
floor structures is the lack of standardized mechanical testing protocols for biological tissue 
samples. To obtain reproducible results when mechanically testing biological samples their 
unique organization, composition and in vivo functions need to be adopted to the mechanical 
testing protocols. Currently mechanical testing of samples from animal or human pelvic floor 
can mainly be tested by uniaxial and biaxial tensile testing. In uniaxial testing, the tissue to 
be tested is placed between two clamps (clamp-to-clamp testing) and a load is applied to the 
sample in one direction while observing for elongation/strain. Uniaxial testing is most com-
monly performed in these studies and it gives more reproducible results.
From a biomechanical point of view, the pelvic floor is a complex structure composed of active 
(e.g. muscles) and passive soft tissue (e.g. fascia) components attached to the pelvic bones all 
Figure 2. Defining the basic mechanical properties of a material by uniaxial mechanical testing. The ‘maximum load’ is 
the maximum amount of stress that a material can bear before it fails. The ‘maximum elongation’ is the maximum strain 
a material can achieve before it fails. The ‘yield strength’ is where irreversible deformation to the material starts.
Synthetic Materials Used in the Surgical Treatment of Pelvic Organ Prolapse: Problems…
http://dx.doi.org/10.5772/intechopen.76671
43
contributing to the mechanical strength [54]. Computational models have the potential to 
mathematically combine all the complex anatomical, mechanical and biochemical data perti-
nent to pelvic floor to create computational models predicting the biomechanical behavior of 
the female pelvic floor in health and disease. Anatomical models demonstrating detailed 3D 
anatomy of the pelvic floor can now be reliably produced thanks to magnetic resonance imag-
ing [55]. The remaining considerable challenge seems to be integrating the functionality of the 
muscles and other soft tissues into these models. The hope they offer is that once an accurate 
biomechanical model is created, population based data can be applied to these models before 
they are used clinically to predict individual patient/disease outcomes.
6.3. Biological requirements of pelvic floor
Early materials implanted into the human body were designed to have appropriate physi-
cal properties to match tissues at the site of implantation and to be made of materials which 
would have minimal toxicity. These materials were biologically ‘inert’ which ensured a minimal 
immune response to the foreign material. Although the consideration of the predicted immune 
response to an implanted material is still conceptually valid, there is a shift of paradigm about 
the inertness of a biomaterial. The next generation of biomaterials were purposefully designed to 
be bioactive to achieve a desired reaction post-implantation (e.g. antibiotic or extracellular matrix 
coated materials). Additionally the degradation times of the materials started to be finely tuned 
with advancements in resorbable biomaterials. The main advantage of using a degradable mate-
rial would be that the foreign material would eventually be degraded after guiding the host to 
achieve a desired tissue regeneration (e.g. absorbable sutures commonly used in surgery).
The polypropylene material commonly used is traditionally considered ‘inert’. Although PPL com-
pletely degrades over many years, its’ inertness is now questioned after repeated demonstrations of 
surface degradation on the PPL fibers [56, 57]. The most common complication of surgical implan-
tation of the mesh is spontaneous pain, occurring in 32.5% patients (pain during sexual intercourse 
14.7%) [58]. The mechanisms leading to this pain are complex, probably involving infection, nerve 
and muscle injury and mesh contraction [59]. It has been demonstrated in mesh samples explanted 
from patients that PPL can actually degrade in vivo as early as 18 months after implantation [56]. 
This PPL polymer can breakdown in response to high temperature, UV light and oxidation [57].
Another important point to consider is the tissue specific immune response to the implanted 
biomaterial. The host immune system, mainly affected by tissue macrophages, initiate a cascade 
of events as soon as the material is implanted in the body. These reactions mainly take place 
at the material-tissue interface meaning that the surface structure and chemistry can poten-
tially influence the initial macrophage response to the implanted material. Modifications of the 
surface properties of materials have been investigated as a potential strategy to shift the mac-
rophage polarization towards a constructive remodeling type (M2) of reaction instead of a pro-
inflammatory (M1) type. A well described pathway leading to biomaterial failure in the long 
term is development of a foreign body reaction leading to encapsulation of the material isolating 
it from the surrounding tissues. A foreign body reaction is a result of chronic M1 predominated 
inflammatory reaction. It has been demonstrated that synthetic materials when designed with a 
highly porous structure elicit less chronic inflammation leading to encapsulation [60, 61].
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It is now widely accepted that the failure of PPL in pelvic floor is due to its mechanical incom-
patibility and the unfavorable mesh-tissue interaction leading to poor tissue integration. 
Essentially the PPL mesh is too strong and not elastic enough to be used in the pelvic floor [62, 63]. 
Additionally, animal studies have confirmed that the host response to the PPL initiated by 
macrophages in the mesh-tissue interface is mainly an M1 (proinflammatory) response, 
instead of an M2 (remodeling) response, characterized by secretion of matrix metallopro-
teinases and pro-inflammatory cytokines leading to a vigorous and persistent foreign body 
reaction [50]. Thus PPL is biologically and mechanically not the best material for pelvic floor 
repair. A recent European consensus report acknowledged the need for more research into 
more acceptable materials for use in the pelvic floor [12].
In conclusion when designing a material for use in the pelvic floor, the design characteristics 
should be optimized to consider its biodegradation and immunological response to it. When 
defining degradability of a material in vivo degradation characteristics and degradation prod-
ucts need to be defined. In case of non-degradable materials the chemical and mechanical 
changes to the material over many years need to be considered. Irrespective of this the host 
response to the material needs to be investigated in terms of both the acute and the longer 
term immunological response to the material. Finally its resistance to infection needs to be 
considered-this is often a combination of the material and its method of implantation.
7. Tissue engineering approaches to design novel materials to be 
used in pelvic floor repair
Tissue engineering and regenerative medicine can meet the clinical need in this area by either 
constructing biodegradable scaffolds that the host cells and tissues can use to remodel or 
directly by constructing a cell-tissue construct for implantation.
Compared to tissue engineering of other organs, such as bone and blood vessels, the area 
of pelvic floor tissue engineering is newly developing necessitating a better understanding 
of pelvic floor anatomy, physiology and mechanics. The first tissue engineered approach to 
construct an autologous fascia equivalent for POP repair was reported in 2010. In this study 
human vaginal fibroblasts were seeded on a PLGA knitted mesh before implantation into 
nude mice for 12 weeks and a well-organized new fascia with a high collagen I/III ratio was 
demonstrated [64]. A stronger tissue engineered material was also constructed from knitted 
silk mesh seeded with adipose derived MSCs in 2013 [65]. In 2013 comparative studies evalu-
ated novel synthetic materials such as polyetheretherketone and polyamide as alternative 
materials to the PPL [66]. A gelatin-coated polyamide knit mesh seeded with endometrial 
MSCs that was designed for POP repair was also shown to reduce inflammatory cell infiltra-
tion and increase neovascularization in a rat model in 2013 [67].
Our own group in Sheffield has also been developing biomaterials and tissue engineered substi-
tutes to be used in pelvic floor repair over the last 6 years. To produce the materials we have selected 
the technique of electrospinning. Electrospinning is a widely used technique in tissue engineer-
ing that allows fabrication of scaffolds with micro/nano sized fibers with different compositions 
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and configurations. With respect to choice of materials for POP we have suggested a biodegrad-
able material, poly-L-lactic acid (PLA). This is a polymer of lactic acid which is among the most 
commonly used polymers in biomedical applications [68]. For a biomaterial to treat stress uri-
nary incontinence (SUI) we have selected a nondegradable polymer of polyurethane Z3-as this 
is not the subject of this chapter this will not be discussed further in this review.
PLA is highly biocompatible and as a degradable polymer it is commonly used as a drug delivery 
material [69]. In one of our first studies with a biodegradable PLA scaffold produced using the 
electrospinning technique we showed that the material was extensively infiltrated by host cells 
together with new collagen deposition and new blood vessel formation after 7 days of implanta-
tion into the rat abdomen [70]. We than tried to mimic the organization of the natural extracel-
lular matrix by spinning transversely, obliquely and irregularly aligned PLA electrospun fibers. 
Here we sought to achieve the viscoelastic mechanical properties of native fascia. We confirmed 
that MSC cells would grow on these fibers and produce new extracellular matrix. This allowed 
us to report in 2016 that electrospun scaffolds with several layers of different polymers to achieve 
the desired biomechanical properties of native fascia [71] maintained good mechanical integrity, 
compared to PPL meshes, over 90 days following implantation using a rabbit model [50]. The 
host response to these multi-layered PLA scaffolds was characterized as a predominantly M2 
(remodeling) type 30 and 90 days after implantation onto the abdomen of the rabbit.
Another crucial requirement to achieve a rapid integration into host issues is related to vascu-
lar supply in and around the biomaterial. This can be particularly concerning in cases where 
the wound bed is already poorly vascularized, such as pelvic floor tissues of postmenopausal 
women with SUI and POP [72]. The growth of new blood vessels into a tissue engineered substi-
tute is crucial to improve its’ tissue integration and to obtain a successful long term clinical out-
come. It has been estimated that a distance of less than 200 μM from the supplying capillary is 
the critical distance for diffusion of oxygen and nutrients to any new tissue introduced into the 
body. Because of this, the survival of any three-dimensional tissue graft relies on rapid develop-
ment of new blood vessels to supply not only the center but also the margins of the graft [73].
Accordingly we have explored the introduction of clinically acceptable agents (specifically 
ascorbic acid and estradiol) that would stimulate neovascularisation and new extra cellular 
matrix production by the patient’s endogenous cells. To this end we have demonstrated effec-
tive pharmacological functionalization of electrospun PLA scaffolds by incorporating ascorbic 
acid into them to stimulate ECM production without compromising mechanical properties [74]. 
We have also recently described an estradiol releasing, biocompatible mesh of electrospun PLA 
which doubled the number of blood vessels in and around the mesh when tested in vivo [75].
8. Conclusion
Polypropylene based vaginal meshes were never designed or tested specifically for use in the 
pelvic floor. The complications associated with the use of these vaginal mesh implants are 
largely due to a poor choice of material. A basic understanding of the material properties in 
relation to the physiological requirements of the site of implantation is essential for those devel-
oping and evaluating materials to assist surgeons seeking to repair the weakened pelvic floor.
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A major limitation here is the relative infancy of the field of urogynecology and our current 
inability to characterize the biomechanical features of the pelvic floor. Despite this there are 
now a small number of academic groups (and a very few number of commercial manufactur-
ers) worldwide engaged in understanding the biomechanical challenges of the pelvic floor, the 
host response to implanted materials and how to develop biomaterials which will be designed 
specifically for use in the pelvic floor to be introduced on their own or with patient derived cells.
Although it is too soon for any of these approaches to have translated into clinical trials there 
are now alternative materials which have been rigorously evaluated in vitro for mechanical 
properties and these are starting to be evaluated in appropriate models (the sheep in Europe 
and monkeys in the US) which can discriminate between materials which will fail mechani-
cally or provoke sustained inflammation and those which do not. There is now reason for 
optimism that better materials can and will be developed which can translate into more effec-
tive surgical support for patients without causing the unacceptably high level of severe side-
effects which patients are currently suffering with PPL mesh.
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